Chris R. Dunk
Impact in
-
- Cancer, Hypoxia, and Metabolism
-
- Cancer Research and Treatments
Papers in
-
- Cancer, Hypoxia, and Metabolism 4
-
- Epigenetics and DNA Methylation 1
- Cancer therapeutics and mechanisms 1
- RNA modifications and cancer 1
- Co-authors
- Mark R. Albertella (4 shared papers)Paul M. Loadman (3 shared papers)Peter A. Harris (5 shared papers)Roger M. Phillips (2 shared papers)Alvin Wong (2 shared papers)Alshad S. Lalani (1 shared paper)R. Rampling (1 shared paper)Philip H. Jones (1 shared paper)
- Journals
- Blood (1 paper)Clinical Cancer Research (1 paper)Cancer Research (1 paper)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- United KingdomLatvia
In The Last Decade
Chris R. Dunk
5 papers receiving 142 citations
Peers
Comparison fields: 5 of 39
- Cancer Research 88
- Biotechnology 20
- Biomedical Engineering 55
- Toxicology 3
- Oncology 22
Countries citing papers authored by Chris R. Dunk
This map shows the geographic impact of Chris R. Dunk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris R. Dunk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris R. Dunk more than expected).
Fields of papers citing papers by Chris R. Dunk
This network shows the impact of papers produced by Chris R. Dunk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris R. Dunk. The network helps show where Chris R. Dunk may publish in the future.
Co-authors
The 24 scholars most cited alongside Chris R. Dunk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 99 | |
| 2 | 2009 | 39 | |
| 3 | In vivo activation of the hypoxia-targeted cytotoxin AQ4N in human tumor xenografts | 2006 | 6 |
| 4 | 2004 | 1 | |
| 5 | The novel hypoxia-targeted anticancer agent AQ4N is not subject to multi-drug resistance mediated by PGP/MDR1 | 2005 | 1 |
About Chris R. Dunk
Chris R. Dunk is a scholar working on Cancer Research, Molecular Biology, Biotechnology, Biomedical Engineering and Organic Chemistry, having authored 5 papers that have together received 146 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (4 papers), Nanoplatforms for cancer theranostics (2 papers), Cancer Research and Treatments (2 papers), Click Chemistry and Applications (1 paper), Epigenetics and DNA Methylation (1 paper), Synthesis and Biological Evaluation (1 paper), Cancer therapeutics and mechanisms (1 paper) and RNA modifications and cancer (1 paper). The work is most often cited by research in Cancer Research (88 citations), Biotechnology (20 citations), Biomedical Engineering (55 citations), Toxicology (3 citations) and Oncology (22 citations). Chris R. Dunk has collaborated with scholars based in United Kingdom and Latvia. Frequent co-authors include Mark R. Albertella, Paul M. Loadman, Peter A. Harris, Roger M. Phillips, Alvin Wong, Alshad S. Lalani, R. Rampling, Philip H. Jones, N.G. Burnet and Alan Anthoney. Their work appears in journals such as Blood, Clinical Cancer Research, Cancer Research and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.